Charles Peyton, M.D. Charles Peyton, M.D., associate professor in the University of Alabama at Birmingham Department of ...
An overview is presented of the PNSAT, a tool for measuring the value of a navigation program from organizational context to community engagement.
A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.
aSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China bDepartment of Obstetrics and Gynecology, National Clinical ...
The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...
Lemond Nutrition, a registered dietitian private practice in Plano, Texas, is joining MYOR, a nationwide community of registered dietitian practices committed to improving health outcomes through ...
Results demonstrated that similar outcomes can be achieved by a human coach-based program and an AI-based program. Moreover, the AI group had higher rates of program initiation (93.4% vs 82.7%) and ...
A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...
STEVENAGE, United Kingdom, Oct. 23, 2025 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is ...
The first national randomized trial of public Montessori preschool students showed stronger long-term outcomes by kindergarten, including elevated reading, memory, and executive function as compared ...
After-school programs are in high demand among families, but mismatches in cost, location and program type can prevent students from accessing the opportunities they need most, according to a new USC ...
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results